Entropy Technologies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,638
Closed -$2.61M 997
2025
Q3
$2.61M Buy
+35,638
New +$2.37M 0.2% 146
2025
Q2
Sell
-11,452
Closed -$731K 875
2025
Q1
$731K Buy
+11,452
New +$665K 0.07% 339
2024
Q3
Sell
-24,969
Closed -$1.31M 816
2024
Q2
$1.31M Buy
+24,969
New +$1.1M 0.14% 206
2024
Q1
Sell
-11,725
Closed -$433K 782
2023
Q4
$433K Buy
+11,725
New +$442K 0.08% 373

Other funds holding HALO

Entropy Technologies's HALO Position: Q4 2025 in Review

Entropy Technologies sold out of Halozyme (HALO) in Q4 2025, closing a stake of 35,638 shares — an estimated $2.61M sold.

Entropy Technologies first reported a position in HALO in Q4 2023 and held it in 4 quarters. The position peaked at $2.61M in Q3 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Entropy Technologies reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Entropy Technologies sold 35,638 Halozyme shares in Q4 2025, an estimated $2.61M.
  • Entropy Technologies first reported a position in Halozyme in Q4 2023 and held it in 4 quarters.
  • Entropy Technologies's Halozyme position peaked at $2.61M in Q3 2025.
  • 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Entropy Technologies's 13F filing for Q4 2025, filed 13 Feb 2026.